|
ZNF264 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.140400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.806400E-02 |
| Normal-vs-Stage2 |
8.068400E-01 |
| Normal-vs-Stage3 |
2.303200E-01 |
| Normal-vs-Stage4 |
1.511430E-01 |
| Stage1-vs-Stage2 |
1.725040E-01 |
| Stage1-vs-Stage3 |
8.37500000000491E-05 |
| Stage1-vs-Stage4 |
8.12930000000378E-05 |
| Stage2-vs-Stage3 |
2.425800E-01 |
| Stage2-vs-Stage4 |
1.807570E-01 |
| Stage3-vs-Stage4 |
7.735400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.554400E-01 |
| Normal-vs-AfricanAmerican |
5.195000E-01 |
| Normal-vs-Asian |
2.538600E-01 |
| Caucasian-vs-AfricanAmerican |
1.974250E-01 |
| Caucasian-vs-Asian |
1.614390E-01 |
| AfricanAmerican-vs-Asian |
8.658100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.868800E-01 |
| Normal-vs-Female |
2.577400E-01 |
| Male-vs-Female |
2.113600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.173400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.862000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.207200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.439210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.234200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.264600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.499760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.235670E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.990400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.857610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.372900E-04 |
| Normal-vs-Grade 2 |
1.601600E-02 |
| Normal-vs-Grade 3 |
5.771600E-01 |
| Normal-vs-Grade 4 |
1.465630E-02 |
| Grade 1-vs-Grade 2 |
4.364400E-02 |
| Grade 1-vs-Grade 3 |
1.439590E-04 |
| Grade 1-vs-Grade 4 |
6.68059999986426E-07 |
| Grade 2-vs-Grade 3 |
1.994420E-04 |
| Grade 2-vs-Grade 4 |
2.31440000053595E-07 |
| Grade 3-vs-Grade 4 |
2.658200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.423510E-03 |
| Normal-vs-ccB subtype |
4.324000E-01 |
| ccA subtype-vs-ccB subtype |
3.30049999996973E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.950800E-01 |
| Normal-vs-N1 |
2.009400E-01 |
| N0-vs-N1 |
1.796570E-01 |
|
|
